Tibor Szarvas

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

International journal of cancer

Prostate cancer and prostatic diseases

BJU international

The Journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Tibor Szarvas, Henning Reis
Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder † . The Journal of pathology 263 (4-5) (2024)
Tibor Szarvas, Henning Reis
Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder † . The Journal of pathology (2024)
Tibor Szarvas
Editorial Comment to Identification of tumor immunophenotypes associated with immunotherapy response in bladder cancer. International journal of urology : official journal of the Japanese Urological Association (2023)
Anita Csizmarik, Nikolett Nagy, Dávid Keresztes, Melinda Váradi, Thilo Bracht, Barbara Sitek, Kathrin E Witzke, Martin Puhr, Ilona Tornyi, József Lázár, László Takács, Gero Kramer, Sabina Sevcenco, Agnieszka Maj-Hes, Boris Hadaschik, Péter Nyirády, Tibor Szarvas
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2023)
Tamás Fazekas, Ádám D Széles, Brigitta Teutsch, Anita Csizmarik, Bálint Vékony, Alex Váradi, Tamás Kói, Zsolt Lang, Nándor Ács, Zsolt Kopa, Péter Hegyi, Boris Hadaschik, Viktor Gruenwald, Péter Nyirády, Tibor Szarvas
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis. Prostate cancer and prostatic diseases (2022)
Michael Wessolly, Fabian D Mairinger, Thomas Herold, Boris Hadaschik, Tibor Szarvas, Henning Reis
Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer. Genes 13 (3) (2022)
Anita Csizmarik, Dávid Keresztes, Nikolett Nagy, Thilo Bracht, Barbara Sitek, Kathrin Witzke, Martin Puhr, Ilona Tornyi, József Lázár, László Takács, Gero Kramer, Sabina Sevcenco, Agnieszka Maj-Hes, Zsolt Jurányi, Boris Hadaschik, Péter Nyirády, Tibor Szarvas
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer. International journal of cancer 151 (8) (2022)
Csilla Olah, Christina Hahnen, Nikolett Nagy, Joanna Musial, Melinda Varadi, Gabor Nyiro, Balazs Gyorffy, Boris Hadaschik, Josefine Rawitzer, Saskia Ting, Gottfrid Sjödahl, Michéle J Hoffmann, Henning Reis, Tibor Szarvas
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genes. International journal of cancer (2021)
Nadina Ortiz-Brüchle, Sophie Wucherpfennig, Michael Rose, Stefan Garczyk, Simone Bertz, Arndt Hartmann, Henning Reis, Tibor Szarvas, András Kiss, Felix Bremmer, Reinhard Golz, Ruth Knüchel, Nadine Therese Gaisa
Molecular Characterization of Muellerian Tumors of the Urinary Tract. Genes 12 (6) (2021)
Magdalena Staniszewska, Pedro Fragoso Costa, Matthias Eiber, Jasmin M Klose, Jasmin Wosniack, Henning Reis, Tibor Szarvas, Boris Hadaschik, Katharina Lückerath, Ken Herrmann, Wolfgang P Fendler, Janette Iking
Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer. International journal of molecular sciences 22 (14) (2021)
Ulrich Krafft, Csilla Olah, Henning Reis, Claudia Kesch, Christopher Darr, Viktor Grünwald, Stephan Tschirdewahn, Boris Hadaschik, Orsolya Horvath, Istvan Kenessey, Peter Nyirady, Melinda Varadi, Orsolya Modos, Anita Csizmarik, Tibor Szarvas
High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy. Cancers 13 (11) (2021)
Nikolett Nagy, Henning Reis, Boris Hadaschik, Christian Niedworok, Orsolya Módos, Attila Szendrői, Krisztina Bíró, Thomas Hager, Thomas Herold, Jason Ablat, Peter C Black, Krzysztof Okon, Yuri Tolkach, Anita Csizmarik, Csilla Oláh, David Keresztes, Felix Bremmer, Nadine T Gaisa, Joerg Kriegsmann, Ilona Kovalszky, András Kiss, József Tímár, Marcell A Szász, Michael Rink, Margit Fisch, Péter Nyirády, Tibor Szarvas
Prevalence of APC and PTEN Alterations in Urachal Cancer. Pathology oncology research : POR 26 (4) (2020)
Tibor Szarvas, Anita Csizmarik, Tamás Fazekas, András Hüttl, Péter Nyirády, Boris Hadaschik, Viktor Grünwald, Lukas Püllen, Zsolt Jurányi, Zsuzsa Kocsis, Shahrokh F Shariat, Sabina Sevcenco, Agnieszka Maj-Hes, Gero Kramer
Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer. BJU international 127 (1) (2020)
Stephan Tschirdewahn, Andrej Panic, Lukas Püllen, Nina N Harke, Boris Hadaschik, Peter Riesz, Andras Horváth, Janos Szalontai, Peter Nyirády, Hideo A Baba, Henning Reis, Tibor Szarvas
Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma. International journal of cancer 145 (2) (2019)
U Krafft, S Tschirdewahn, J Hess, N N Harke, B A Hadaschik, P Nyirády, A Szendröi, M Szücs, O Módos, C Olah, E Székely, H Reis, Tibor Szarvas
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients. Pathology oncology research : POR 26 (2) (2019)
Tibor Szarvas, Sabina Sevcenco, Orsolya Módos, Dávid Keresztes, Péter Nyirády, Anita Csizmarik, Robin Ristl, Martin Puhr, Michèle J Hoffmann, Christian Niedworok, Boris Hadaschik, Agnieszka Maj-Hes, Shahrokh F Shariat, Gero Kramer
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer. BJU international 122 (4) (2018)

Tibor Szarvas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tibor Szarvas